Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ITAREPS Trial: A Prospective Randomized Double-blind Controlled Study in IT-aided Mobile Phone-based Relapse Prevention Program in Schizophrenia.

NCT00712660 is registered in ClinicalTrials.gov with Prague Psychiatric Center as lead sponsor.

NCT NCT00712660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00712660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ITAREPS Trial: A Prospective Randomized Double-blind Controlled Study in IT-aided Mobile Phone-based Relapse Prevention Program in Schizophrenia.
Lead sponsor
Prague Psychiatric Center
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2008
Completion date
March 31, 2012
Enrollment
146 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia